These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1383210)

  • 21. Maternal high density lipoproteins affect fetal mass and extra-embryonic fetal tissue sterol metabolism in the mouse.
    McConihay JA; Honkomp AM; Granholm NA; Woollett LA
    J Lipid Res; 2000 Mar; 41(3):424-32. PubMed ID: 10706590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes.
    Bonn V; Cheung RC; Chen B; Taghibiglou C; Van Iderstine SC; Adeli K
    Atherosclerosis; 2002 Jul; 163(1):59-68. PubMed ID: 12048122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice.
    Plummer MR; Hasty AH
    J Nutr Biochem; 2008 Oct; 19(10):664-73. PubMed ID: 18280133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.
    Valenta DT; Bulgrien JJ; Banka CL; Curtiss LK
    Atherosclerosis; 2006 Dec; 189(2):255-63. PubMed ID: 16423356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
    Chajek-Shaul T; Hayek T; Walsh A; Breslow JL
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6731-5. PubMed ID: 1907375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive.
    Duvillard L; Dautin G; Florentin E; Jeannin A; Pais de Barros JP; Lagrost L; Petit JM; Gambert P; Vergès B
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4891-7. PubMed ID: 19858317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
    Nichols AV; Blanche PJ; Shore VG; Gong EL
    Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.
    Hayek T; Azrolan N; Verdery RB; Walsh A; Chajek-Shaul T; Agellon LB; Tall AR; Breslow JL
    J Clin Invest; 1993 Sep; 92(3):1143-52. PubMed ID: 8376576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dehydroepiandrosterone on rat apolipoprotein AI gene expression in the human hepatoma cell line, HepG2.
    Deleon MJ; Horani MH; Haas MJ; Wong NC; Mooradian AD
    Metabolism; 2002 Mar; 51(3):376-9. PubMed ID: 11887177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.
    Gillard BK; Bassett GR; Gotto AM; Rosales C; Pownall HJ
    J Biol Chem; 2017 May; 292(21):8864-8873. PubMed ID: 28373285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I.
    Masson D; Duverger N; Emmanuel F; Lagrost L
    J Biol Chem; 1997 Sep; 272(39):24287-93. PubMed ID: 9305883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.
    Allan CM; Fidge NH; Morrison JR; Kanellos J
    Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):449-55. PubMed ID: 7680856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.
    Pastier D; Dugué S; Boisfer E; Atger V; Tran NQ; van Tol A; Chapman MJ; Chambaz J; Laplaud PM; Kalopissis AD
    Biochemistry; 2001 Oct; 40(41):12243-53. PubMed ID: 11591143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hyperinsulinemia does not increase the production rate of high-density lipoprotein apolipoprotein AI: evidence from a kinetic study in patients with insulinoma.
    Duvillard L; Florentin E; Pont F; Petit JM; Baillot-Rudoni S; Penfornis A; Vergès B
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2460-5. PubMed ID: 23908245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
    Wang WQ; Moses AS; Francis GA
    Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits.
    Koike T; Koike Y; Yang D; Guo Y; Rom O; Song J; Xu J; Chen Y; Wang Y; Zhu T; Garcia-Barrio MT; Fan J; Chen YE; Zhang J
    Atherosclerosis; 2021 Jan; 316():32-40. PubMed ID: 33296791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
    J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.